Announcements Trials
Browse Landscape

Phase

Phase 1 274Phase 1/2 102Phase 2 16Phase EARLY_PHASE1 8Phase NA 4Phase 2/3 2Phase 4 1

Status

Unknown 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1328Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 321Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Interventions

tislelizumab 1anlotinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Advanced Solid Tumor × Clear all
NCT06367751 2026-03-11

LIQPLAT

University Hospital, Basel, Switzerland

Phase NA Active not recruiting
159 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting
13 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03163732 2022-05-09

PROFILER 02

Centre Leon Berard

Phase NA Completed
341 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03929965 2019-04-29

Anlotinib in Advanced Solid Tumors With FGFR Alteration

Shanghai Changzheng Hospital

Phase NA Unknown
30 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡